基本信息
浏览量:263
职业迁徙
个人简介
Dr. Tyler Curiel is a physician-scientist with clinical expertise in phase I experimental therapeutics and gynecologic cancers. His laboratory expertise is in human immunology with an emphasis on understanding the immunopathologic basis of human diseases including cancer, infections and autoimmunity.
He has significant administrative expertise as past chief of two different academic divisions of hematology and medical oncology, director of a general clinical research center and executive director of an NCI-designated cancer center. He translates his groups discoveries into novel clinical trials.
Selected Publications
Hasty P, Livi CB, Dodds SG, Jones D, Strong R, Javors M, Fischer KE, Sloane L, Murthy K, Hubbard G, Sun L, Hurez V, Curiel TJ, Sharp ZD. eRapa restores a normal life span in a FAP mouse model. Cancer Prev Res (Phila). 2014 Jan;7(1):169-78.
Tomihara K, Curiel TJ, Zhang B. Optimization of immunotherapy in elderly cancer patients. Crit Rev Oncog. 2013;18(6):573-83.
Hasty P, Sharp ZD, Curiel TJ, Campisi J. mTORC1 and p53: clash of the gods? Cell Cycle. 2013 Jan 1;12(1):20-5.
Wang L, Fan J, Chen S, Zhang Y, Curiel TJ, Zhang B. Graft-versus-host disease is enhanced by selective CD73 blockade in mice.PLoS One. 2013;8(3):e58397.
Chakravarty D, Roy SS, Babu CR, Dandamudi R, Curiel TJ, Vivas-Mejia P, Lopez-Berestein G, Sood AK, Vadlamudi RK. Therapeutic targeting of PELP1 prevents ovarian cancer growth and metastasis. Clin Cancer Res. 2011 Apr 15;17(8):2250-9.
He has significant administrative expertise as past chief of two different academic divisions of hematology and medical oncology, director of a general clinical research center and executive director of an NCI-designated cancer center. He translates his groups discoveries into novel clinical trials.
Selected Publications
Hasty P, Livi CB, Dodds SG, Jones D, Strong R, Javors M, Fischer KE, Sloane L, Murthy K, Hubbard G, Sun L, Hurez V, Curiel TJ, Sharp ZD. eRapa restores a normal life span in a FAP mouse model. Cancer Prev Res (Phila). 2014 Jan;7(1):169-78.
Tomihara K, Curiel TJ, Zhang B. Optimization of immunotherapy in elderly cancer patients. Crit Rev Oncog. 2013;18(6):573-83.
Hasty P, Sharp ZD, Curiel TJ, Campisi J. mTORC1 and p53: clash of the gods? Cell Cycle. 2013 Jan 1;12(1):20-5.
Wang L, Fan J, Chen S, Zhang Y, Curiel TJ, Zhang B. Graft-versus-host disease is enhanced by selective CD73 blockade in mice.PLoS One. 2013;8(3):e58397.
Chakravarty D, Roy SS, Babu CR, Dandamudi R, Curiel TJ, Vivas-Mejia P, Lopez-Berestein G, Sood AK, Vadlamudi RK. Therapeutic targeting of PELP1 prevents ovarian cancer growth and metastasis. Clin Cancer Res. 2011 Apr 15;17(8):2250-9.
研究兴趣
论文共 394 篇作者统计合作学者相似作者
按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Behnam Ebrahimi,Suryavathi Viswanadhapalli,Uday P. Pratap,Rahul Gopalam,Xue Yang,Prabhakar P. Venkata, Viktor Drel,Bindu Santhamma,Swapna Konda,Xiaonan Li, Alondra L. Rodriguez Sanchez,Hui Yan,
Cancer Researchno. 6_Supplement (2024): 5998-5998
Shaun Trecarten,Robert S. Svatek,Niannian Ji,Zhen-Ju Shu,Tyler J. Curiel,Neelam Mukherjee, Jamie Furman
Urologic Oncology: Seminars and Original Investigations (2024)
crossref(2023)
crossref(2023)
crossref(2023)
crossref(2023)
Lyndsay V. Rhodes,Sarah P. Short,Nicole F. Neel, Virgilio A. Salvo, Yun Zhu,Steven Elliott,Yongkun Wei,Dihua Yu,Menghong Sun,Shannon E. Muir, Juan P. Fonseca,Melyssa R. Bratton,
crossref(2023)
crossref(2023)
IMMUNITYno. 11 (2023): 2570-+
crossref(2023)
加载更多
作者统计
合作学者
合作机构
D-Core
- 合作者
- 学生
- 导师
数据免责声明
页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果,我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问,可以通过电子邮件方式联系我们:report@aminer.cn